Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 06-2000 | 12-1999 | 06-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -9,636 | N/A | -11,278 | -11,810 |
| Depreciation Amortization | 970 | 974 | 970 | 979 | 960 |
| Accounts receivable | N/A | 382 | N/A | -80 | N/A |
| Other Working Capital | -920 | -1,016 | -660 | -680 | -1,150 |
| Other Operating Activity | 860 | 572 | 190 | 288 | 0 |
| Operating Cash Flow | $910 | $-8,724 | $500 | $-10,771 | $-12,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -124 | -730 | -737 | -330 |
| Purchase Of Investment | N/A | -46,534 | N/A | -15,817 | N/A |
| Sale Of Investment | N/A | 22,702 | N/A | 9,879 | N/A |
| Other Investing Activity | -23,830 | 0 | -5,930 | 0 | 8,990 |
| Investing Cash Flow | $-23,950 | $-23,956 | $-6,660 | $-6,675 | $8,660 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 450 | N/A |
| Debt Repayment | N/A | -144 | N/A | -78 | N/A |
| Common Stock Issued | N/A | 42,660 | N/A | 850 | N/A |
| Dividend Paid | 0 | -536 | 0 | N/A | 0 |
| Other Financing Activity | 39,670 | -1,656 | 13,560 | 12,125 | 4,880 |
| Financing Cash Flow | $39,670 | $40,325 | $13,560 | $13,347 | $4,880 |
| Beginning Cash Position | N/A | 3,469 | N/A | 7,568 | 6,010 |
| End Cash Position | N/A | 11,114 | N/A | 3,469 | 7,560 |
| Net Cash Flow | $16,630 | $7,645 | $7,400 | $-4,099 | $1,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | 910 | -8,724 | 500 | -10,771 | -12,000 |
| Capital Expenditure | N/A | -124 | N/A | -737 | N/A |
| Free Cash Flow | 910 | -8,848 | 500 | -11,508 | -12,000 |